These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6754328)

  • 41. [Pathogenesis of tracheal stenosis following long-term intubation of patients with multiple injuries].
    Balluch H
    HNO; 1983 Nov; 31(11):395-8. PubMed ID: 6654713
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human factor XIII: fibrin-stabilizing factor.
    Lorand L; Losowsky MS; Miloszewski KJ
    Prog Hemost Thromb; 1980; 5():245-90. PubMed ID: 7422874
    [No Abstract]   [Full Text] [Related]  

  • 43. Factor XIII-activity and fibrin subunit structure in acute leukemia.
    Rasche H; Dietrich M; Gaus W; Schleyer M
    Biomedicine; 1974 Feb; 21(2):61-6. PubMed ID: 4527804
    [No Abstract]   [Full Text] [Related]  

  • 44. Factor XIII concentrate for prevention of recurrent subarachnoid hemorrhage: results of a multicenter pilot study. The FISAH Study Group.
    Thie A; Henze T
    Neurochirurgia (Stuttg); 1991 Jul; 34(4):107-10. PubMed ID: 1922628
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ranitidine versus cimetidine in the management of acute upper gastrointestinal tract bleeding.
    Thomson AB; Maguire T; Wensel RH; Sherbaniuk RW; Bailey RJ; Kirdeikis P
    J Clin Gastroenterol; 1984 Aug; 6(4):295-9. PubMed ID: 6090529
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Decreased factor XIII activity during severe Henoch-Schoenlein purpura -- does it play a role?
    Prenzel F; Pfäffle R; Thiele F; Schuster V
    Klin Padiatr; 2006; 218(3):174-6. PubMed ID: 16688675
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Congenital deficiency of factor XIII caused by two missense mutations in a Dutch family.
    Onland W; Böing AN; Meijer AB; Schaap MC; Nieuwland R; Haasnoot K; Sturk A; Peters M
    Haemophilia; 2005 Sep; 11(5):539-47. PubMed ID: 16128900
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Deficiency of blood coagulation factor XIII in Crohn's disease.
    Oshitani N; Kitano A; Hara J; Suzuki N; Aoki T; Yasuda K; Watanabe Y; Obayashi M; Obata A; Nakamura S
    Am J Gastroenterol; 1995 Jul; 90(7):1116-8. PubMed ID: 7611208
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Randomized clinical trial of fibrin sealant in patients undergoing resternotomy or reoperation after cardiac operations. A multicenter study.
    Rousou J; Levitsky S; Gonzalez-Lavin L; Cosgrove D; Magilligan D; Weldon C; Hiebert C; Hess P; Joyce L; Bergsland J
    J Thorac Cardiovasc Surg; 1989 Feb; 97(2):194-203. PubMed ID: 2464722
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Safety, pharmacokinetics, and immunogenicity of single-dose rFXIII administration to healthy volunteers.
    Reynolds TC; Butine MD; Visich JE; Gunewardena KA; MacMahon M; Pederson S; Bishop PD; Morton KM
    J Thromb Haemost; 2005 May; 3(5):922-8. PubMed ID: 15869585
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [A study of oral mucosal ulcers in leukemia patients (changes in plasma coagulation factor XIII levels].
    Tamashige M; Takebe M; Goto Y; Matsuda K; Inou T; Chiba H
    Rinsho Byori; 1997 Feb; Suppl 104():25-36. PubMed ID: 9128360
    [No Abstract]   [Full Text] [Related]  

  • 52. A pasteurised concentrate of human plasma factor XIII for therapeutic use.
    Winkelman L; Sims GE; Haddon ME; Evans DR; Smith JK
    Thromb Haemost; 1986 Jun; 55(3):402-5. PubMed ID: 3750269
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The half life of factor XIII in the management of inherited deficiency.
    Fear JD; Miloszewski KJ; Losowsky MS
    Thromb Haemost; 1983 Apr; 49(2):102-5. PubMed ID: 6868004
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Therapeutic factor XIII preparations and perspectives for recombinant factor XIII.
    Karges HE; Metzner HJ
    Semin Thromb Hemost; 1996; 22(5):427-36. PubMed ID: 8989827
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Factor XIII and its substrates, fibronectin, fibrinogen, and alpha 2-antiplasmin, in plasma and urine of patients with nephrosis.
    Vaziri ND; Gonzales E; Barton CH; Chen HT; Nguyen Q; Arquilla M
    J Lab Clin Med; 1991 Feb; 117(2):152-6. PubMed ID: 1993857
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prophylactic and perioperative replacement therapy for acquired factor XIII deficiency.
    Lim W; Moffat K; Hayward CP
    J Thromb Haemost; 2004 Jun; 2(6):1017-9. PubMed ID: 15140148
    [No Abstract]   [Full Text] [Related]  

  • 57. Acute and diffuse postoperative bleeding after free latissimus dorsi flap--Factor XIII deficiency: a case report and review of the literature.
    Dragu A; Bach AD; Leffler M; Unglaub F; Horch RE
    Med Sci Monit; 2009 Jan; 15(1):CS1-4. PubMed ID: 19114970
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The use of recombinant factor XIII in a major bleeding episode of a patient with congenital factor XIII deficiency--the first experience.
    Árokszállási A; Kerényi A; Katona É; Bereczky Z; Muszbek L; Boda Z; Schlammadinger Á
    Haemophilia; 2015 Jan; 21(1):e118-21. PubMed ID: 25471755
    [No Abstract]   [Full Text] [Related]  

  • 59. [Therapeutic action of coagulation factor XIII in scleroderma. 20 cases].
    Thivolet J; Perrot H; Meunier F; Bouchet B
    Nouv Presse Med; 1975 Nov; 4(39):2779-82. PubMed ID: 1105424
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acquired factor XIII deficiency: still a clinical challenge in the era of novel therapy.
    Tha MH; Tien SL
    Haemophilia; 2014 Jan; 20(1):e104-5. PubMed ID: 24354481
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.